0001209191-13-030665.txt : 20130604
0001209191-13-030665.hdr.sgml : 20130604
20130604202852
ACCESSION NUMBER: 0001209191-13-030665
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130604
FILED AS OF DATE: 20130604
DATE AS OF CHANGE: 20130604
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Babich Michael L
CENTRAL INDEX KEY: 0001368078
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 13892967
MAIL ADDRESS:
STREET 1: TWO BALA PLAZA
STREET 2: SUITE 300
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-06-04
0
0001516479
Insys Therapeutics, Inc.
INSY
0001368078
Babich Michael L
444 SOUTH ELLIS STREET
CHANDLER
AZ
85224
1
1
0
0
President and CEO
Common Stock
2013-06-04
4
P
0
1250
10.9287
A
77557
D
The weighted average sales price for the transaction reported was $10.92872, and the range of prices were between $10.924 and $10.9299. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
/s/ Michael Babich
2013-06-04